Invention Grant
- Patent Title: Use of adenovirus and nucleic acids coding therefor
-
Application No.: US16704669Application Date: 2019-12-05
-
Publication No.: US11268073B2Publication Date: 2022-03-08
- Inventor: Per Sonne Holm
- Applicant: Per Sonne Holm
- Applicant Address: DE Furstenfeldbruck
- Assignee: Per Sonne Holm
- Current Assignee: Per Sonne Holm
- Current Assignee Address: DE Furstenfeldbruck
- Agency: Casimir Jones, S.C.
- Priority: DE10223534.1 20020527,DE10225400.1 20020607,DE10248039.7 20021015,DE10322530.7 20030519
- Main IPC: A61K35/761
- IPC: A61K35/761 ; C12N7/00 ; C07K14/005 ; C12N15/86 ; A61K35/763 ; A61K38/00 ; A61K48/00
Abstract:
This invention relates to the use of an adenovirus to treat cancer, for example. The adenovirus may be replication deficient in cells that lack Y box binding protein. The adenovirus may encode an oncogene or an oncogene product, which may transactivate at least one viral gene.
Public/Granted literature
- US20200095560A1 USE OF ADENOVIRUS AND NUCLEIC ACIDS CODING THEREFOR Public/Granted day:2020-03-26
Information query
